Riverwater Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $781K | Buy |
1,927
+267
| +16% | +$108K | 0.37% | 87 |
|
|
2025
Q1 | $826K | Sell |
1,660
-152
| -8% | -$75.6K | 0.42% | 74 |
|
|
2024
Q4 | $943K | Buy |
1,812
+91
| +5% | +$47.3K | 0.46% | 64 |
|
|
2024
Q3 | $1.05M | Sell |
1,721
-27
| -2% | -$16.5K | 0.52% | 60 |
|
|
2024
Q2 | $967K | Sell |
1,748
-28
| -2% | -$15.5K | 0.72% | 35 |
|
|
2024
Q1 | $1.03M | Sell |
1,776
-17
| -0.9% | -$9.88K | 0.76% | 27 |
|
|
2023
Q4 | $952K | Buy |
1,793
+14
| +0.8% | +$7.43K | 0.75% | 28 |
|
|
2023
Q3 | $900K | Sell |
1,779
-12
| -0.7% | -$6.07K | 0.82% | 28 |
|
|
2023
Q2 | $934K | Sell |
1,791
-13
| -0.7% | -$6.78K | 0.83% | 29 |
|
|
2023
Q1 | $1.04M | Sell |
1,804
-551
| -23% | -$318K | 0.95% | 22 |
|
|
2022
Q4 | $1.3M | Buy |
2,355
+111
| +5% | +$61.1K | 1.11% | 19 |
|
|
2022
Q3 | $1.14M | Buy |
2,244
+157
| +8% | +$79.6K | 1.14% | 15 |
|
|
2022
Q2 | $1.13M | Buy |
2,087
+1,085
| +108% | +$590K | 1.14% | 11 |
|
|
2022
Q1 | $592K | Sell |
1,002
-1,156
| -54% | -$683K | 0.98% | 43 |
|
|
2021
Q4 | $1.44M | Buy |
+2,158
| New | +$1.44M | 1.28% | 9 |
|